本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Sarepta Therapeutics

20.83
-0.0900-0.43%
成交量:132.67萬
成交額:2,753.29萬
市值:21.99億
市盈率:-15.83
高:21.06
開:20.81
低:20.29
收:20.92
52周最高:25.32
52周最低:14.68
股本:1.06億
流通股本:9,905.26萬
量比:0.43
換手率:1.34%
股息:- -
股息率:- -
每股收益(TTM):-1.3161
每股收益(LYR):-7.1300
淨資產收益率:-9.48%
總資產收益率:-1.13%
市淨率:1.44
市盈率(LYR):-2.92

資料載入中...

2026/08/13

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/07

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/06

重要事件披露

Form 8-K - Current report
2026/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/31

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/30

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/29

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/07/27

重要事件披露

Form 8-K - Current report
2026/06/04

重要事件披露

Form 8-K - Current report
2026/06/04

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/05/07

重要事件披露

Form 8-K - Current report
2026/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/29

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/25

重要事件披露

Form 8-K - Current report
2026/02/25

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2025/12/19

重要事件披露

Form 8-K - Current report